|
Lymphoid Neoplasia
Citations 261-270 of 299 total displayed.
|
Past content
(since Jan 2009):
|
Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia
- Yoshiko Atsuta, Ritsuro Suzuki, Tokiko Nagamura-Inoue, Shuichi Taniguchi, Satoshi Takahashi, Shunro Kai, Hisashi Sakamaki, Yasushi Kouzai, Masaharu Kasai, Takahiro Fukuda, Hiroshi Azuma, Minoko Takanashi, Shinichiro Okamoto, Masahiro Tsuchida, Keisei Kawa, Yasuo Morishima, Yoshihisa Kodera, Shunichi Kato, and for the Japan Marrow Donor Program and the Japan Cord Blood Bank Network
Blood 2009; 113: 1631-1638.
[Abstract]
[Full text]
[PDF]
Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors
- Masako Iwanaga, Masuko Tagawa, Kunihiro Tsukasaki, Tatsuki Matsuo, Ken-ichi Yokota, Yasushi Miyazaki, Takuya Fukushima, Tomoko Hata, Yoshitaka Imaizumi, Daisuke Imanishi, Jun Taguchi, Sabro Momita, Shimeru Kamihira, and Masao Tomonaga
Blood 2009; 113: 1639-1650.
[Abstract]
[Full text]
[PDF]
Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases
- Ila Joshi, Lisa M. Minter, Janice Telfer, Renée M. Demarest, Anthony J. Capobianco, Jon C. Aster, Piotr Sicinski, Abdul Fauq, Todd E. Golde, and Barbara A. Osborne
Blood 2009; 113: 1689-1698.
[Abstract]
[Full text]
[PDF]
Small molecule XIAP inhibitors cooperate with TRAIL to induce apoptosis in childhood acute leukemia cells and overcome Bcl-2–mediated resistance
- Melanie Fakler, Sandra Loeder, Meike Vogler, Katja Schneider, Irmela Jeremias, Klaus-Michael Debatin, and Simone Fulda
Blood 2009; 113: 1710-1722.
[Abstract]
[Full text]
[PDF]
AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines
- Dana S. Levy, Jason A. Kahana, and Rakesh Kumar
Blood 2009; 113: 1723-1729.
[Abstract]
[Full text]
[PDF]
NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity
- Florence Armstrong, Philippe Brunet de la Grange, Bastien Gerby, Marie-Christine Rouyez, Julien Calvo, Michaéla Fontenay, Nicolas Boissel, Hervé Dombret, André Baruchel, Judith Landman-Parker, Paul-Henri Roméo, Paola Ballerini, and Françoise Pflumio
Blood 2009; 113: 1730-1740.
[Abstract]
[Full text]
[PDF]
Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century
- Dianne Pulte, Adam Gondos, and Hermann Brenner
Blood 2009; 113: 1408-1411.
[Abstract]
[Full text]
[PDF]
Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy
- Tim M. Illidge, Mike Bayne, Nicholas S. Brown, Samantha Chilton, Mark S. Cragg, Martin J. Glennie, Yong Du, Valerie Lewington, James Smart, James Thom, Maureen Zivanovic, and Peter W. M. Johnson
Blood 2009; 113: 1412-1421.
[Abstract]
[Full text]
[PDF]
BLNK suppresses pre–B-cell leukemogenesis through inhibition of JAK3
- Joji Nakayama, Mutsumi Yamamoto, Katsuhiko Hayashi, Hitoshi Satoh, Kenji Bundo, Masato Kubo, Ryo Goitsuka, Michael A. Farrar, and Daisuke Kitamura
Blood 2009; 113: 1483-1492.
[Abstract]
[Full text]
[PDF]
Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors
- Dan Rauch, Shimon Gross, John Harding, Stefan Niewiesk, Michael Lairmore, David Piwnica-Worms, and Lee Ratner
Blood 2009; 113: 1493-1500.
[Abstract]
[Full text]
[PDF]
|
|
